Solving Kids' Cancer Inc

“The completed form 990 is sent to the board of directors for review and approval prior to filing.”

“The organization distributes a conflict of interest policy to each board member annually at the board meeting. All staff and board members are required to sign a conflict of interest policy statement. Any conflicts that arise during the course of the year are required to be disclosed and resolved before the transaction is completed.”

“Compensation is determined by conducting a fair market value comparison of other organizations by the board chair. Factors include the number of hours worked and the breadth of roles and responsibilities.”

“Compensation is determined by conducting a fair market value comparison of other organizations by the board chair. Factors include the number of hours worked and the breadth of roles and responsibilities.”

“The organization's governing documents and form 990 are made available upon request.”

“Skc impacts children through the initiation of clinical research trials of investigative treatment strategies. Our vision is to continue expanding the armamentarium of effective and less toxic treartment strategies for pediatric oncologistcs to utilize until long-term survival is a reality for all children with high-risk solid tumors and brain tumors. To accomplish our mission, skc funds and advocates for breakthrough treatment options to improve survival outcomes for children with the most fatal pediatric cancers through collaborative partnerships with the research community and related nonprofit stakeholders.”

“Skc leadership and scientific advisors survey, discuss, and prioritize the areas of greatest unmet need within the pediatric cancer research landscape and develop specific programs to address them. 1. Skc conceived and organized the 2025 care for rare global strategy forum, inviting the world's top experts in embryonal tumor with multilayered rosettes (etmr) and atypical teratoid rhabdoid tumor (atrt), two rare and aggressive brain tumors that affect very young chiildren. The objectives of the meeting are to facilitate the exchange of information around existing research projects and build collaborations across continents. 2. Skc initiated and facilitated the pediatric brain tumor research network (pbtrn) meetings, bringing together researchers in the nyc area from the top six institutions three times per year to share research data and build collaborations. 3. Skc has advisory roles on national and international clinical trials consortia, regulatory bodies, multi stakeholder platform for pediatric cancer drug development, pharmaceutical companies, and builds collaborations with other nonprofits to advocate for and fund research. Skc reviews proposals for the nci funded children's oncology group and the department of defense rare cancer research programmatic panel. Skc was invited to serve on panels and present at seven scientific meetings in five countries. Skc co-authored several peer-reviewed journal articles and pediatric oncology textbook chapters. These roles give skc opportunity to influence research agendas and priorities.”

“Consulting 0 0 48,000 other contracted services 0 0 26,825 total 0 0 74,825”